PCK2 and malignant colon neoplasm: Park et al. have shown that the down-regulation of PEPCK-M leads to reduced proliferation of the colon cancer cell line SNU-C4 and increased survival of SNU-C4 cells treated with a combination of 5-FU and radiation.